Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Pharmacoeconomics
|
June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluations
Ben Kearns, Roberta Ara, Allan Wailoo, et al.
BMC Health Services Research
|
January 26, 2017
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation
Ben Kearns, R Rafia, J Leaviss, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 12, 2019
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement
Helen Bell Gorrod, Ben Kearns, John Stevens, et al.
BMC Public Health
|
July 29, 2016
Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study
Jessica Li, Mark Green, Ben Kearns, et al.
BMC Health Services Research
|
April 30, 2013
Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community
Jonathan Tosh, Ben Kearns, Alan Brennan, et al.
Health Technology Assessment (Winchester, England)
|
June 29, 2026
Placental growth factor (PLGF)-based testing to help diagnose suspected pre-eclampsia: a systematic review and economic evaluation
Jonathan Shepherd, Geoff Frampton, Ben Kearns, et al.
Health Technology Assessment (Winchester, England)
|
November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model
Sue Harnan, Ben Kearns, Alison Scope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
Stephen Palmer, Isabelle Borget, Tim Friede, et al.
Applied Health Economics and Health Policy
|
June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Beth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy
|
November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Beth Woods, Ben Kearns, Laetitia Schmitt, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Pharmacoeconomics
|
June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluations
Ben Kearns, Roberta Ara, Allan Wailoo, et al.
BMC Health Services Research
|
January 26, 2017
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation
Ben Kearns, R Rafia, J Leaviss, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 12, 2019
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement
Helen Bell Gorrod, Ben Kearns, John Stevens, et al.
BMC Public Health
|
July 29, 2016
Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study
Jessica Li, Mark Green, Ben Kearns, et al.
BMC Health Services Research
|
April 30, 2013
Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community
Jonathan Tosh, Ben Kearns, Alan Brennan, et al.
Health Technology Assessment (Winchester, England)
|
June 29, 2026
Placental growth factor (PLGF)-based testing to help diagnose suspected pre-eclampsia: a systematic review and economic evaluation
Jonathan Shepherd, Geoff Frampton, Ben Kearns, et al.
Health Technology Assessment (Winchester, England)
|
November 2, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model
Sue Harnan, Ben Kearns, Alison Scope, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
Stephen Palmer, Isabelle Borget, Tim Friede, et al.
Applied Health Economics and Health Policy
|
June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Beth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy
|
November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Beth Woods, Ben Kearns, Laetitia Schmitt, et al.
Page
of 3